FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3120675089> ?p ?o ?g. }

• W3120675089 endingPage "233" @default.
• W3120675089 startingPage "226" @default.
• W3120675089 abstract "Abstract Background Neutropenia is an adverse effect of vincristine when used in multidrug chemotherapy protocols. Objective To determine the incidence of neutropenia, identify potential risk factors for neutropenia, and determine the effect of neutropenia on outcome, in dogs receiving vincristine for treatment of immune‐mediated thrombocytopenia (ITP). Animals One hundred twenty‐seven client‐owned dogs presumptively diagnosed with ITP. Methods In this retrospective cohort study, medical records were reviewed to identify dogs presumptively diagnosed with ITP, and treated with vincristine, over a 15‐year period. Logistic regression was used to identify risk factors for the development of neutropenia in dogs receiving vincristine. Time to platelet count ≥40 000 platelets/μL, survival, and duration of hospitalization were compared between neutropenic and non‐neutropenic dogs. Results Vincristine was administered to 127 dogs with presumptive ITP; 19 became neutropenic. Administration of cyclosporine was significantly ( P < .001) associated with the development of neutropenia (odds ratio: 12.97, 95% confidence interval: 4.17, 40.35). There was no difference in median time to ≥40 000 platelets/μL between neutropenic dogs (4 days; range, 1‐14 days) and non‐neutropenic dogs (3 days; range, 0‐48 days). Percentage survival to discharge was 95% in both groups, but median duration of hospitalization was significantly longer in neutropenic dogs (6 days; range, 3‐22 days) compared to non‐neutropenic dogs (4 days; range, 2‐15 days). Conclusions and Clinical Importance Cyclosporine administration was associated with the development of neutropenia in dogs receiving vincristine, which might be related to effects on metabolism of vincristine. Neutrophil counts should be monitored in dogs receiving vincristine treatment for ITP, particularly if administered in conjunction with cyclosporine." @default.
• W3120675089 created "2021-01-18" @default.
• W3120675089 creator A5014348159 @default.
• W3120675089 creator A5057591919 @default.
• W3120675089 creator A5078960232 @default.
• W3120675089 date "2021-01-01" @default.
• W3120675089 modified "2023-09-26" @default.
• W3120675089 title "Neutropenia in dogs receiving vincristine for treatment of presumptive immune‐mediated thrombocytopenia" @default.
• W3120675089 cites W144570554 @default.
• W3120675089 cites W1493849072 @default.
• W3120675089 cites W1948043450 @default.
• W3120675089 cites W1968469975 @default.
• W3120675089 cites W1974930253 @default.
• W3120675089 cites W1977199676 @default.
• W3120675089 cites W1979804110 @default.
• W3120675089 cites W1987467289 @default.
• W3120675089 cites W1998483135 @default.
• W3120675089 cites W2003567723 @default.
• W3120675089 cites W2016997848 @default.
• W3120675089 cites W2046937425 @default.
• W3120675089 cites W2054739351 @default.
• W3120675089 cites W2059054910 @default.
• W3120675089 cites W2064965130 @default.
• W3120675089 cites W2071856833 @default.
• W3120675089 cites W2073795369 @default.
• W3120675089 cites W2083644765 @default.
• W3120675089 cites W2101855721 @default.
• W3120675089 cites W2108488335 @default.
• W3120675089 cites W2109900827 @default.
• W3120675089 cites W2112114428 @default.
• W3120675089 cites W2119399347 @default.
• W3120675089 cites W2143831053 @default.
• W3120675089 cites W2751087684 @default.
• W3120675089 cites W2886893841 @default.
• W3120675089 cites W2973232476 @default.
• W3120675089 cites W3120675089 @default.
• W3120675089 cites W4237088923 @default.
• W3120675089 cites W4237769560 @default.
• W3120675089 cites W4249710322 @default.
• W3120675089 doi "https://doi.org/10.1111/jvim.16029" @default.
• W3120675089 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7848356" @default.
• W3120675089 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33421218" @default.
• W3120675089 hasPublicationYear "2021" @default.
• W3120675089 type Work @default.
• W3120675089 sameAs 3120675089 @default.
• W3120675089 citedByCount "3" @default.
• W3120675089 countsByYear W31206750892021 @default.
• W3120675089 countsByYear W31206750892022 @default.
• W3120675089 countsByYear W31206750892023 @default.
• W3120675089 crossrefType "journal-article" @default.
• W3120675089 hasAuthorship W3120675089A5014348159 @default.
• W3120675089 hasAuthorship W3120675089A5057591919 @default.
• W3120675089 hasAuthorship W3120675089A5078960232 @default.
• W3120675089 hasBestOaLocation W31206750891 @default.
• W3120675089 hasConcept C120665830 @default.
• W3120675089 hasConcept C121332964 @default.
• W3120675089 hasConcept C126322002 @default.
• W3120675089 hasConcept C167135981 @default.
• W3120675089 hasConcept C197934379 @default.
• W3120675089 hasConcept C2776694085 @default.
• W3120675089 hasConcept C2776755627 @default.
• W3120675089 hasConcept C2777063308 @default.
• W3120675089 hasConcept C2779429289 @default.
• W3120675089 hasConcept C2780873365 @default.
• W3120675089 hasConcept C44249647 @default.
• W3120675089 hasConcept C61511704 @default.
• W3120675089 hasConcept C71924100 @default.
• W3120675089 hasConceptScore W3120675089C120665830 @default.
• W3120675089 hasConceptScore W3120675089C121332964 @default.
• W3120675089 hasConceptScore W3120675089C126322002 @default.
• W3120675089 hasConceptScore W3120675089C167135981 @default.
• W3120675089 hasConceptScore W3120675089C197934379 @default.
• W3120675089 hasConceptScore W3120675089C2776694085 @default.
• W3120675089 hasConceptScore W3120675089C2776755627 @default.
• W3120675089 hasConceptScore W3120675089C2777063308 @default.
• W3120675089 hasConceptScore W3120675089C2779429289 @default.
• W3120675089 hasConceptScore W3120675089C2780873365 @default.
• W3120675089 hasConceptScore W3120675089C44249647 @default.
• W3120675089 hasConceptScore W3120675089C61511704 @default.
• W3120675089 hasConceptScore W3120675089C71924100 @default.
• W3120675089 hasIssue "1" @default.
• W3120675089 hasLocation W31206750891 @default.
• W3120675089 hasLocation W31206750892 @default.
• W3120675089 hasLocation W31206750893 @default.
• W3120675089 hasLocation W31206750894 @default.
• W3120675089 hasLocation W31206750895 @default.
• W3120675089 hasOpenAccess W3120675089 @default.
• W3120675089 hasPrimaryLocation W31206750891 @default.
• W3120675089 hasRelatedWork W1542568406 @default.
• W3120675089 hasRelatedWork W1999706042 @default.
• W3120675089 hasRelatedWork W2058955695 @default.
• W3120675089 hasRelatedWork W2364106504 @default.
• W3120675089 hasRelatedWork W2375424399 @default.
• W3120675089 hasRelatedWork W2375501759 @default.
• W3120675089 hasRelatedWork W2378088005 @default.
• W3120675089 hasRelatedWork W2401101517 @default.
• W3120675089 hasRelatedWork W2409812054 @default.
• W3120675089 hasRelatedWork W2418393430 @default.

• next